ADXN — ADDEX THERAPEUTICS LTD
Public company
InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.
Sourced from SEC EDGAR public filings
Why are billionaires buying ADXN?
Built from public SEC filings and public economic data. Not a recommendation.
Why? — Evidence & Confidence ▾
Of 1 tracked investors who changed their ADXN position last quarter, 1 bought and 0 sold (100% buy-side). Macro conditions are a headwind for this sector (Macro Tailwind 38/100 in a Expansion regime).
- +1 tracked investor added or increased positions last quarter (Ken Griffin)
- +1 tracked investors reported holding ADXN at their latest filing
- −Current Expansion regime has historically been a headwind for this sector (Macro Tailwind 38/100)
- −13F data is disclosed up to 45 days after quarter end — positions may have changed since
- · 13F disclosure lag (up to 45 days)
- · Tracked investors are a sample, not the whole market
- · Sector regime fit is a historical average, not a guarantee
Every InvestorLens score shows its evidence — including what argues against it. Model conviction-v1 · generated 11/22/2026.
About ADDEX THERAPEUTICS LTD (ADXN)
ADDEX THERAPEUTICS LTD (ADXN) appears in the most recent 13F filings of 1 tracked institutional investor. The largest disclosed position is held by Ken Griffin (Citadel Advisors), valued at $86,179. Across recent filings, tracked investors recorded 1 new positions, 0 increased, 1 reduced, and 1 exited. All data sourced from SEC 13F filings.
Based on recent institutional activity in ADXN
How many top investors track ADXN
Only 1 tracked investor report this position.
ADXN Ownership Composition
How ADDEX THERAPEUTICS LTD is held across tracked investor types, based on reported 13F positions.
- Multi-Strategy / Quant100.0%
Tracked investors currently reporting ADXN
- Ken GriffinSep 30, 2026Citadel AdvisorsShares14.9KValue$41.2K% Portfolio0.00%
Recent activity
- New$41.2KNov 16, 2026
- Reduced$86.2K(-2.80%)May 15, 2025
- Sold$0(-100.00%)Aug 14, 2025
Frequently asked questions
- How many institutional investors hold ADXN?
- 1 tracked institutional investor disclosed a position in ADXN (ADDEX THERAPEUTICS LTD) in their most recent 13F filing.
- Who is the largest institutional holder of ADXN?
- Ken Griffin, Citadel Advisors, holds the largest disclosed position in ADXN, valued at $86,179.
- Did institutional ownership of ADXN increase or decrease?
- Across recent 13F filings, tracked investors recorded 1 new positions, 0 increased, 1 reduced, and 1 fully exited ADXN.
- Where does this ADXN ownership data come from?
- SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.